These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Temporising management of severe pre-eclampsia with and without the HELLP syndrome.
    Author: Visser W, Wallenburg HC.
    Journal: Br J Obstet Gynaecol; 1995 Feb; 102(2):111-7. PubMed ID: 7756201.
    Abstract:
    OBJECTIVE: To test the null hypothesis that the course and outcome of pregnancy in patients with severe pre-eclampsia receiving temporising haemodynamic treatment does not depend on the presence or absence of the syndrome of haemolysis, elevated liver enzymes, and a low platelet count (HELLP). DESIGN: A case-controlled study. SETTING: High risk obstetric unit, University Hospital Rotterdam-Dijkzigt, Rotterdam. SUBJECTS: One hundred and twenty-eight consecutive pre-eclamptic patients with HELLP, gestational age less than 34 weeks, matched for maternal and gestational age with 128 pre-eclamptic patients without HELLP. INTERVENTION: Both groups were treated with volume expansion and pharmacologic vasodilatation under invasive haemodynamic monitoring with the aim of prolonging gestation and enhancing fetal maturity. MAIN OUTCOME MEASURES: Maternal and perinatal outcome in patients with and without HELLP. RESULTS: Except for variables pertaining to HELLP, clinical and laboratory data and median prolongation of pregnancy did not differ between both groups. Complete reversal of HELLP occurred in 43% of patients. Perinatal mortality was 14.1% in HELLP patients and 14.8% in patients without HELLP. No maternal complications occurred. CONCLUSION: We cannot reject the null hypothesis. Our data do not support a general recommendation of prompt termination of pregnancy in HELLP. Temporising treatment may improve fetal and neonatal as well as maternal outcome.
    [Abstract] [Full Text] [Related] [New Search]